ClearPoint Neuro (NASDAQ: CLPT)
ClearPoint Neuro Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
ClearPoint Neuro Company Info
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.
News & Analysis
Valuation
Earnings Transcripts
ClearPoint Neuro, Inc. (CLPT) Q2 2022 Earnings Call Transcript
CLPT earnings call for the period ending June 30, 2022.
ClearPoint Neuro, Inc. (CLPT) Q1 2022 Earnings Call Transcript
CLPT earnings call for the period ending March 31, 2022.
ClearPoint Neuro, Inc. (CLPT) Q4 2021 Earnings Call Transcript
CLPT earnings call for the period ending December 31, 2021.
ClearPoint Neuro, Inc. (CLPT) Q3 2021 Earnings Call Transcript
CLPT earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.